摘要
Ovarian cancer is one of the leading causes of death in female reproductive system cancers. However, the pathogenesis of ovarian cancer remains elusive. Our aim is to investigate the potential targets for ovarian cancer. Two microarray datasets were obtained from the Gene Expression Omnibus public database. Using R package limma, the differentially expressed genes (DEGs) were identified from the datasets. There were 95 overlapping DEGs in two microarray datasets. GO, KEGG pathway analysis, and protein-protein interaction (PPI) network analysis were carried out based on the DEGs. Wnt signaling pathway and cell cycle were enriched in the KEGG pathway analysis. Moreover, the top 10 hub genes with the most nodes were determined by PPI network analysis. E2F8, one of hub genes was positively linked to a bad outcome in ovarian cancer patients. Furthermore, E2F8 knockdown suppressed cell proliferation and induced cell cycle arrest in ovarian cancer. In addition, we found that silencing E2F8 inhibited the Wnt/beta-catenin signaling pathway. In ovarian cancer cells with E2F8 knockdown, overexpressing beta-catenin restored both the suppressed capacity of cell proliferation and cell cycle progression. Therefore, our results revealed that E2F8 had an involvement in the development of ovarian cancer which might act as a therapeutic target.
学科与关键词
- Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics AnalysisLi, Chao*; Hong, Zhantong; Ou, Miaoling; Zhu, Xiaodan; Zhang, Linghua; Yang, XingkunBiomed Research International, 2021, 2021: 6673655.被引 3
- Al-NAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathwayCai, Yanlin; Hu, Yi; Yu, Furong; Tong, Wenjuan; Wang, Shufen; Sheng, Shunliang*; Zhu, Jiayu*Aging-US, 2021, 13(20): 23579-23587.被引 11
- UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosisZhang, Mengjun; Liu, Yuan; Yin, Yue; Sun, Zhenxing; Wang, Yan; Zhang, Zexue; Li, Fei; Chen, Xiuwei*Molecular Medicine, 2022, 28(1): 62.被引 12
